- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Elpro International Ltd has acquired 95,454 equity shares of Natco Pharma Limited for an investment of INR 10.01 Cr. This strategic move, funded by cash, marks Elpro's entry into the pharmaceutical sector through an investment in Natco Pharma, a global leader known for its innovation in niche pharmaceutical products and expansions into new markets. Natco Pharma reported a consolidated turnover of 4,784.00 Cr for FY 2024-25. This acquisition diversifies Elpro's investment portfolio into a growing industry, signaling a potential long-term play for shareholders.